1.1.2. Articolo in Rivista

1.1.2. Articolo in Rivista - Letter: [926] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 881 a 900 di 926

Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC

2024-01-01 Dekervel, J.; Casadei-Gardini, A.; Pinter, M.

Comparison of BASILICA and Balloon-Assisted BASILICA Coronary Protection for Redo-TAVR: Insights From Bench Testing

2023-01-01 Beneduce, A.; Khokhar, A. A.; Curio, J.; Giannini, F.; Zlahoda-Huzior, A.; Grant, D.; Maisano, F.; De Backer, O.; Sathananthan, J.; Dudek, D.

Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco

2024-01-01 Conti, F.; Pontiggia, S.; Morena, V.; Alberton, F.; Badalucco, F.; Molteni, C.; Bradanini, L.; Pandolfo, A.; Galli, L.; Castagna, A.; Piconi, S.

The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr. Oncol. 2023, 30, 1882–1892

2023-01-01 May, M.; Lebentrau, S.; Ayres, B.; Albersen, M.; Protzel, C.; Chahoud, J.; Brouwer, O. R.; Pettaway, C. A.; Pagliaro, L. C.; Necchi, A.; Watkin, N.; Hakenberg, O. W.; Spiess, P. E.

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer

2023-01-01 Fallara, G.; Robesti, D.; Raggi, D.; Montorsi, F.; Necchi, A.; Cooperberg, M. R.; Malavaud, B.; Ploussard, G.; Martini, A.

Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis

2023-01-01 Cigliola, A.; Mercinelli, C.; Patane, D.; Raggi, D.; Necchi, A.

Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials

2024-01-01 Raggi, D.; Cigliola, A.; Mercinelli, C.; Patane, D.; Tateo, V.; Bosi, C.; Crupi, E.; Gandaglia, G.; Briganti, A.; Necchi, A.

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter

2023-01-01 Moschini, M.; Necchi, A.; Briganti, A.; Montorsi, F.

Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly

2023-01-01 Necchi, A.; Joshi, M.; Bangs, R.; Makaroff, L.; Grivas, P.; Kamat, A. M.; Kassouf, W.; Raggi, D.; Marandino, L.; Krupski, T.; Flaig, T. W.; Spiess, P. E.

Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?

2023-01-01 Bandini, M.; Nini, A.; Briganti, A.; Necchi, A.; Montorsi, F.

Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107–14

2023-01-01 Basile, G.; Bandini, M.; Montorsi, F.; Necchi, A.

Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007

2024-01-01 Gandaglia, G.; Briganti, A.; Raggi, D.; Marandino, L.; Necchi, A.; Di Maio, M.; Montorsi, F.

Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

2024-01-01 Moschini, M.; Necchi, A.; Montorsi, F.

Beyond the kidneys: investigating airway involvement in autosomal dominant polycystic kidney disease through nasal nitric oxide profiling: A transversal single-center observational study

2024-01-01 De Rosa, L. I.; Vespa, M.; Catania, M.; Kola, K.; Bucci, R.; Mancassola, G.; Carrera, P.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.

Low-Cardiac Output Syndrome After Tricuspid Valve Repair: Insights From the TriValve Registry

2023-01-01 Rommel, K. P.; Taramasso, M.; Ludwig, S.; Bonnet, G.; Thiele, H.; Leon, M. B.; Maisano, F.; Burkhoff, D.; Hahn, R. T.; Lurz, P.

A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes

2024-01-01 Gargano, G.; Vegliante, M. C.; Esposito, F.; Pappagallo, S. A.; Sabattini, E.; Agostinelli, C.; Pileri, S. A.; Tabanelli, V.; Ponzoni, M.; Lorenzi, L.; Facchetti, F.; Napoli, A. D.; Lucioni, M.; Paulli, M.; Leoncini, L.; Lazzi, S.; Ascani, S.; Opinto, G.; Zaccaria, G. M.; Volpe, G.; Mondelli, P.; Bucci, A.; Selicato, L.; Negri, A.; Loseto, G.; Clemente, F.; Scattone, A.; Zito, A. F.; Nassi, L.; Del Buono, N.; Guarini, A.; Ciavarella, S.

Power is Nothing Without Control: Are Artificial Intelligence Chatbots in Vascular Diseases Tested and Verified?

2024-01-01 Melissano, G.; Tinelli, G.; Soderlund, T.

Maternal plasma markers in intrauterine growth restriction and small for gestational age complicated pregnancy: the role of sFlt-1/PlGF

2023-01-01 Libretti, A.; Valsecchi, L.; Zerbini, G.; Remorgida, V.; Candiani, M.

Menopause and bipolar disorder: Bridging research gaps and exploring postmenopause

2024-01-01 Attanasio, F.; Fazio, V.; Pira, C.; Manfredi, E.; Fregna, L.; Colombo, C.

A European platform trial for major depressive disorder

2026-01-01 Gold, Stefan M; Brasanac, Jelena; Benedetti, Francesco; Grootendorst, Nina; Hoogendijk, Witte; Köhler-Forsberg, Ole; König, Franz; Mäntylä, Fanni-Laura; Michon, Amelie; Pariante, Carmine M; Posch, Martin; Ramos-Quiroga, J Antoni; Otte, Christian

Titolo	Data di pubblicazione	Autore(i)
Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC	1-gen-2024	Dekervel, J.; Casadei-Gardini, A.; Pinter, M.
Comparison of BASILICA and Balloon-Assisted BASILICA Coronary Protection for Redo-TAVR: Insights From Bench Testing	1-gen-2023	Beneduce, A.; Khokhar, A. A.; Curio, J.; Giannini, F.; Zlahoda-Huzior, A.; Grant, D.; Maisano, F.; De Backer, O.; Sathananthan, J.; Dudek, D.
Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco	1-gen-2024	Conti, F.; Pontiggia, S.; Morena, V.; Alberton, F.; Badalucco, F.; Molteni, C.; Bradanini, L.; Pandolfo, A.; Galli, L.; Castagna, A.; Piconi, S.
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr. Oncol. 2023, 30, 1882–1892	1-gen-2023	May, M.; Lebentrau, S.; Ayres, B.; Albersen, M.; Protzel, C.; Chahoud, J.; Brouwer, O. R.; Pettaway, C. A.; Pagliaro, L. C.; Necchi, A.; Watkin, N.; Hakenberg, O. W.; Spiess, P. E.
Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer	1-gen-2023	Fallara, G.; Robesti, D.; Raggi, D.; Montorsi, F.; Necchi, A.; Cooperberg, M. R.; Malavaud, B.; Ploussard, G.; Martini, A.
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis	1-gen-2023	Cigliola, A.; Mercinelli, C.; Patane, D.; Raggi, D.; Necchi, A.
Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials	1-gen-2024	Raggi, D.; Cigliola, A.; Mercinelli, C.; Patane, D.; Tateo, V.; Bosi, C.; Crupi, E.; Gandaglia, G.; Briganti, A.; Necchi, A.
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter	1-gen-2023	Moschini, M.; Necchi, A.; Briganti, A.; Montorsi, F.
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly	1-gen-2023	Necchi, A.; Joshi, M.; Bangs, R.; Makaroff, L.; Grivas, P.; Kamat, A. M.; Kassouf, W.; Raggi, D.; Marandino, L.; Krupski, T.; Flaig, T. W.; Spiess, P. E.
Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment?	1-gen-2023	Bandini, M.; Nini, A.; Briganti, A.; Necchi, A.; Montorsi, F.
Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107–14	1-gen-2023	Basile, G.; Bandini, M.; Montorsi, F.; Necchi, A.
Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007	1-gen-2024	Gandaglia, G.; Briganti, A.; Raggi, D.; Marandino, L.; Necchi, A.; Di Maio, M.; Montorsi, F.
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial	1-gen-2024	Moschini, M.; Necchi, A.; Montorsi, F.
Beyond the kidneys: investigating airway involvement in autosomal dominant polycystic kidney disease through nasal nitric oxide profiling: A transversal single-center observational study	1-gen-2024	De Rosa, L. I.; Vespa, M.; Catania, M.; Kola, K.; Bucci, R.; Mancassola, G.; Carrera, P.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.
Low-Cardiac Output Syndrome After Tricuspid Valve Repair: Insights From the TriValve Registry	1-gen-2023	Rommel, K. P.; Taramasso, M.; Ludwig, S.; Bonnet, G.; Thiele, H.; Leon, M. B.; Maisano, F.; Burkhoff, D.; Hahn, R. T.; Lurz, P.
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes	1-gen-2024	Gargano, G.; Vegliante, M. C.; Esposito, F.; Pappagallo, S. A.; Sabattini, E.; Agostinelli, C.; Pileri, S. A.; Tabanelli, V.; Ponzoni, M.; Lorenzi, L.; Facchetti, F.; Napoli, A. D.; Lucioni, M.; Paulli, M.; Leoncini, L.; Lazzi, S.; Ascani, S.; Opinto, G.; Zaccaria, G. M.; Volpe, G.; Mondelli, P.; Bucci, A.; Selicato, L.; Negri, A.; Loseto, G.; Clemente, F.; Scattone, A.; Zito, A. F.; Nassi, L.; Del Buono, N.; Guarini, A.; Ciavarella, S.
Power is Nothing Without Control: Are Artificial Intelligence Chatbots in Vascular Diseases Tested and Verified?	1-gen-2024	Melissano, G.; Tinelli, G.; Soderlund, T.
Maternal plasma markers in intrauterine growth restriction and small for gestational age complicated pregnancy: the role of sFlt-1/PlGF	1-gen-2023	Libretti, A.; Valsecchi, L.; Zerbini, G.; Remorgida, V.; Candiani, M.
Menopause and bipolar disorder: Bridging research gaps and exploring postmenopause	1-gen-2024	Attanasio, F.; Fazio, V.; Pira, C.; Manfredi, E.; Fregna, L.; Colombo, C.
A European platform trial for major depressive disorder	1-gen-2026	Gold, Stefan M; Brasanac, Jelena; Benedetti, Francesco; Grootendorst, Nina; Hoogendijk, Witte; Köhler-Forsberg, Ole; König, Franz; Mäntylä, Fanni-Laura; Michon, Amelie; Pariante, Carmine M; Posch, Martin; Ramos-Quiroga, J Antoni; Otte, Christian

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 881 a 900 di 926

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext435
reserved344
open146
partially open1